PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för CGS 15943. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

14 hits

Bibliografisk träff 2014-02-12

Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.

Edling CE, Selvaggi F, Ghonaim R, Maffucci T, Falasca M.

Cancer Biol Ther · research support, non-u.s. gov't; research-article; journal article · DOI 10.4161/cbt.28018

Bibliografisk träff 1999-07-01

Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys.

Holtzman SG.

Eur J Pharmacol · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0014-2999(99)00346-5

Bibliografisk träff 1999-01-01

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.

Ongini E, Dionisotti S, Gessi S, Irenius E, Fredholm BB.

Naunyn Schmiedebergs Arch Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/pl00005326

Bibliografisk träff 1996-07-01

Myocardial adenosine A1 and A2 receptor activities during juvenile and adult stages of development.

Sawmiller DR, Fenton RA, Dobson JG.

Am J Physiol · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1152/ajpheart.1996.271.1.h235

Bibliografisk träff 1996-05-01

Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines.

Holtzman SG.

J Pharmacol Exp Ther · comparative study; research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0022-3565(25)12929-7

Bibliografisk träff 1994-12-01

Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice.

Imaizumi M, Miyazaki S, Onodera K.

Methods Find Exp Clin Pharmacol · journal article

Bibliografisk träff 1994-01-01

CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil.

Gao Y, Phillis JW.

Life Sci · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/0024-3205(94)00889-2

Bibliografisk träff 1993-10-01

Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.

Howell LL, Byrd LD.

J Pharmacol Exp Ther · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0022-3565(25)39502-9

Bibliografisk träff 1993-08-01

Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys.

Howell LL.

J Pharmacol Exp Ther · comparative study; research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0022-3565(25)38357-6

Bibliografisk träff 1991-05-01

Do adenosinergic substrates mediate methylxanthine effects upon reinforcement thresholds for electrical brain stimulation in the rat?

Mumford GK, Holtzman SG.

Brain Res · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/0006-8993(91)90425-u

Bibliografisk träff 1991-01-01

CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.

Holtzman SG.

Life Sci · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/0024-3205(91)90329-a

Bibliografisk träff 1991-01-01

Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice.

Czuczwar SJ, Janusz W, Szczepanik B, Kleinrok Z.

J Neural Transm Gen Sect · journal article · DOI 10.1007/bf01250573

Bibliografisk träff 1991-01-01

Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.

Jarvis MF, Williams M, Do UH, Sills MA.

Mol Pharmacol · journal article · DOI 10.1016/s0026-895x(25)10917-6

Bibliografisk träff 1987-05-01

Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.

Williams M, Francis J, Ghai G, Braunwalder A, Psychoyos S, Stone GA, Cash WD.

J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-5347(25)00258-7